Clinical Trials Browser

Interventional × Hemorrhage × 90 days × Clear all

Hemorrhage, Myofibroma

NCT07410117 2026-04-09

ROXI-CAT-I

Phase 3 Recruiting

860 enrolled

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT05198960 2026-03-20

AVAJAK

Phase 3 Recruiting

1,308 enrolled

Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT06229483 2026-03-19

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Phase 3 Recruiting

102 enrolled

CNS

Brain Neoplasms, Hemorrhage

NCT07401303 2026-02-27

Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time

Phase NA Not yet recruiting

640 enrolled

Gastrointestinal

Hemorrhage, Stomach Neoplasms

NCT07372716 2026-02-06

ACE-HIGH

Phase NA Not yet recruiting

700 enrolled

Atrial Fibrillation, Hemorrhage, Neoplasms, Thrombosis, Venous Thrombosis

NCT07390864 2026-02-05

Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy

Phase NA Recruiting

40 enrolled

Hemorrhage, Myofibroma

NCT07352761 2026-01-20

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

Phase NA Recruiting

60 enrolled

Hemorrhage, Leiomyoma, Blood Loss, Surgical

Clinical Trials

Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet

ROXI-CAT-I

AVAJAK

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time

ACE-HIGH

Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy